Texas Yale Capital Corp. Novartis Ag Transaction History
Texas Yale Capital Corp.
- $2.42 Billion
- Q1 2025
A detailed history of Texas Yale Capital Corp. transactions in Novartis Ag stock. As of the latest transaction made, Texas Yale Capital Corp. holds 3,952 shares of NVS stock, worth $460,921. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,952
Previous 3,952
-0.0%
Holding current value
$460,921
Previous $384,000
14.58%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding NVS
# of Institutions
1,544Shares Held
141MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.38 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.21 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$1 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$823 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$789 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $251B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...